Home > Healthcare > Biotechnology > Bioservices > Spatial OMICS Market

Spatial OMICS Market Share

Report ID: GMI9050
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Spatial OMICS Market Share

The spatial OMICS industry is characterized by the presence of several key players offering innovative products. The strategic partnerships, mergers, and acquisitions are common strategies employed by players to expand their market presence, enhance their service portfolios, and gain a competitive advantage.

Spatial OMICS Market Companies

Prominent players operating in the spatial OMICS industry include:

10x Genomics
Akoya Biosciences, Inc.
Bio-Techne Corporation
BioSpyder, Inc.
Bruker Corporation
Danaher Corporation
Diagenode Diagnostics (Hologic, Inc.)
Ionpath, Inc.
Millennium Science Pty Ltd.
NanoString Technologies, Inc.
PerkinElmer, Inc.
S2 Genomics, Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Spatial OMICS market was valued at USD 384.4 million in 2023 and is expected grow at 14.3% CAGR from 2024 – 2032, attributed to the increasing adoption of spatial genomics & transcriptomics and proteomics techniques in research and clinical applications.

The spatial transcriptomics segment accounted for USD 217.3 million, due to its ability to provide a comprehensive understanding of the spatial organization of gene expression within tissues.

North America spatial OMICS industry accounted for USD 167.7 million in 2023 and is anticipated to grow at 14.1% CAGR between 2024 – 2032, owing to well-established healthcare infrastructure and technological advancements in genomics and bioinformatics.

10x Genomics, Akoya Biosciences, Inc., Bio-Techne Corporation, BioSpyder, Inc., Bruker Corporation, Danaher Corporation, Diagenode Diagnostics (Hologic, Inc.), Ionpath, Inc., Millennium Science Pty Ltd., NanoString Technologies, Inc., PerkinElmer, Inc. and S2 Genomics, Inc.